Characterization and Evaluation of Nano-niosomes Encapsulating Docetaxel against Human Breast, Pancreatic, and Pulmonary Adenocarcinoma Cancer Cell Lines
Background: Docetaxel (DXL) is an antineoplastic agent for cancer treatment, the therapeutic efficiency of which is limited due to low solubility, hydrophobicity, and tissue specificity.Objective: In this study, nano-niosomes were introduced for improving therapeutic index of DXL.Material and Method...
Main Authors: | Mohammadreza Ajdari, Aliyeh Ranjbar, Khashayar Karimian, Maryam Karimi, Hossein Heli, Naghmeh Sattarahmady |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2024-04-01
|
Series: | Journal of Biomedical Physics and Engineering |
Subjects: | |
Online Access: | https://jbpe.sums.ac.ir/article_49905_c919399ba6fd9af9f792059b06ce4209.pdf |
Similar Items
-
Re‐evaluation of sorbitan monostearate (E 491), sorbitan tristearate (E 492), sorbitan monolaurate (E 493), sorbitan monooleate (E 494) and sorbitan monopalmitate (E 495) when used as food additives
by: EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), et al.
Published: (2017-05-01) -
Safety for the environment of sorbitan monolaurate as a feed additive for all animal species
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2020-06-01) -
Safety and efficacy of sorbitan monolaurate as a feed additive for all animal species
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (EFSA FEEDAP Panel), et al.
Published: (2019-03-01) -
Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
by: Dipika S. Gaikwad, et al.
Published: (2023-05-01) -
New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles
by: Atefeh Hekmat, et al.
Published: (2016-09-01)